Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_assertion type Assertion NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_head.
- NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_assertion description "[Furthermore, low E2F-1 expression and p16INK4A inactivation may serve as prognostic markers for patients with this type of lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_provenance.
- NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_assertion evidence source_evidence_literature NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_provenance.
- NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_assertion SIO_000772 10803523 NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_provenance.
- NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_assertion wasDerivedFrom befree-2016 NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_provenance.
- NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_assertion wasGeneratedBy ECO_0000203 NP283312.RAOaSNeIAmv_wV-PwIE132oQ2_Zo5Idy8RPKAz01c2Bpw130_provenance.